From the National Institutes of Health. Report of a workshop on clinical studies of the efficacy of amantadine and rimantadine against influenza vireus.
D000218:Adamantane / Q000031:analogs & derivatives / Q000627:therapeutic use*; D000547:Amantadine / Q000627:therapeutic use*; D001952:Bridged-Ring Compounds / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004341:Drug Evaluation; D006801:Humans; D066298:In Vitro Techniques; D007251:Influenza, Human / Q000517:prevention & control*; D008824:Michigan; D009316:National Institutes of Health (U.S.); D009975:Orthomyxoviridae / Q000187:drug effects; D010919:Placebos; D014481:United States
D001952:Bridged-Ring Compounds; D010919:Placebos; D000547:Amantadine; D000218:Adamantane